文献速递甲状腺疾病

基于机器学习的青少年甲亢甲巯咪唑剂量调整模型开发

Development of a Machine Learning-based Model for Methimazole Dosage Adjustment in Youth With Hyperthyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2026-01-01

本研究开发并验证了基于机器学习的模型,用于预测青少年甲亢患者的最佳甲巯咪唑日剂量。研究使用1512次就诊数据训练模型,并在666次和31次就诊的外部验证队列中验证。XGBoost模型表现最佳,内部验证MAE为1.72 mg,外部验证MAE为1.08 mg。SHAP分析显示既往MMI剂量、T3和游离T4水平是关键预测因子。

要点

  • XGBoost模型在预测青少年甲亢MMI剂量上表现最佳,外部验证MAE为1.08 mg。
  • 关键预测变量包括既往MMI剂量、T3和游离T4水平。
  • 该工具为首个数据驱动的青少年甲亢MMI剂量指导工具,可能提高临床效率。

核心结论

  • XGBoost模型在内部验证中MAE为1.72 mg,外部验证中MAE为1.08 mg,表现最佳。
  • SHAP分析识别既往MMI剂量、T3和游离T4水平为关键预测因子。

研究设计与样本

  • 回顾性多中心模型开发研究,训练集来自1512次就诊,外部验证集分别来自666次和31次就诊。
  • 研究对象为年龄≤18岁的青少年甲亢患者。

主要发现

  • XGBoost模型内部验证MAE为1.72 mg,外部验证MAE为1.08 mg。
  • 线性回归、决策树、支持向量回归和前馈神经网络也被训练和验证。

临床怎么用

  • 该数据驱动工具可用于指导青少年甲亢患者的MMI剂量调整,提高临床效率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Accurate methimazole (MMI) dose adjustment in pediatric hyperthyroidism is crucial, but individualized titration relies on clinician experience due to a lack of validated predictive tools. OBJECTIVE: This study aimed to develop and validate machine learning-based models for predicting optimal MMI dosage in pediatric hyperthyroidism. DESIGN: This was a retrospective, multicenter, model-development study. Machine learning models, including linear regression, decision tree, support vector regression, Extreme Gradient Boosting (XGBoost), and feed-forward neural networks, were trained and validated. SETTING: Data were collected from a primary center for model training, with 2 separate centers providing data for external validation. PATIENTS OR OTHER PARTICIPANTS: Data were derived from 1512 visits for the training set and 666 and 31 visits for 2 external validation cohorts, respectively. All data were from youth aged ≤18 years with hyperthyroidism. INTERVENTIONS: The models were trained to predict the optimal daily dosage of MMI based on variables including age, sex, anthropometric measures, prior MMI dosage, treatment duration, and current and previous results of thyroid function tests. MAIN OUTCOME MEASURES: Model performance was evaluated by the mean absolute error (MAE) between the predicted and actual MMI dosages. Feature importance was determined using Shapley additive explanations (SHAP) analysis. RESULTS: The XGBoost model demonstrated the best performance in both internal validation (MAE 1.72 mg) and external validation (MAE 1.08 mg). SHAP analysis identified previous MMI dose, T3, and free T4 levels as key predictors. CONCLUSION: This study introduces the first data-driven tool to guide MMI dosing in pediatric hyperthyroidism, which can improve clinical efficiency.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Kim JY, Lee K, Choi E, et al. Development of a Machine Learning-based Model for Methimazole Dosage Adjustment in Youth With Hyperthyroidism. J Clin Endocrinol Metab. 2026. PMID: 41058080. doi:10.1210/clinem/dgaf542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。